ID

29269

Beschreibung

DA-EDOCH14-R in Poor-prognosis Diffuse Large B-cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01066429

Link

https://clinicaltrials.gov/show/NCT01066429

Stichworte

Versionen (1)
  1. 14.03.18 14.03.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

14. März 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diffuse Large B-Cell Lymphoma (DLBCL) NCT01066429

Englisch

Eligibility Diffuse Large B-Cell Lymphoma (DLBCL) NCT01066429

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
signing the informed consent.
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
histology: diffuse large b-cell lymphoma de novo (primary mediastinal b-cell lymphomas will be included provided that they have a mass greater than 7 cm in larger diameter) and follicular nhl grade 3b.
Beschreibung

Diffuse Large B-Cell Lymphoma de novo | Primary Mediastinal Large B-Cell Lymphoma Mass Diameter | Follicular Lymphoma Ann Arbor lymphoma staging system

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0079744
UMLS CUI [1,2]
C1515568
UMLS CUI [2,1]
C1292754
UMLS CUI [2,2]
C1306372
UMLS CUI [2,3]
C1301886
UMLS CUI [3,1]
C0024301
UMLS CUI [3,2]
C0432516
aaipi: 2-3.
Beschreibung

International Prognostic Index Adjusted Age

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1512894
UMLS CUI [1,2]
C3831006
age: between 18 and 70 years.
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
general condition (ecog/who): proper organic function, defined by: fevi ≥ 40%, serum creatinine < 150 µmol/l, serum bilirubin < 30 µmol/l, control of other medical conditions such as: infection, leukocytes ≥ 3.5 x 109/l and platelets ≥ 100 x 109/l (except if they are caused by lymphomatous infiltration of bone marrow or of the spleen).
Beschreibung

General finding of patient ECOG performance status | General finding of patient WHO performance status scale | Organ function | FEV1 | Creatinine measurement, serum | Serum total bilirubin measurement | Communicable Disease control | White Blood Cell Count procedure | Platelet Count measurement | Exception Lymphomatous infiltration Bone Marrow | Exception Lymphomatous infiltration Spleen

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0424449
UMLS CUI [1,2]
C1520224
UMLS CUI [2,1]
C0424449
UMLS CUI [2,2]
C1298650
UMLS CUI [3]
C0678852
UMLS CUI [4]
C0849974
UMLS CUI [5]
C0201976
UMLS CUI [6]
C1278039
UMLS CUI [7,1]
C0009450
UMLS CUI [7,2]
C0243148
UMLS CUI [8]
C0023508
UMLS CUI [9]
C0032181
UMLS CUI [10,1]
C1705847
UMLS CUI [10,2]
C2960101
UMLS CUI [10,3]
C0005953
UMLS CUI [11,1]
C1705847
UMLS CUI [11,2]
C2960101
UMLS CUI [11,3]
C0037993
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
hiv-positive.
Beschreibung

HIV Seropositivity

Datentyp

boolean

Alias
UMLS CUI [1]
C0019699
pregnancy or breastfeeding.
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
serious disease compromising the performance of the therapeutic regimen.
Beschreibung

Disease Serious compromises Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C2945640
UMLS CUI [1,4]
C0087111
recent history of another malignant disease (except skin cancer different from melanoma or carcinoma in-situ of the cervix), prior radiotherapy or chemotherapy, history of indolent lymphoma.
Beschreibung

Malignant disease Other | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix | Prior radiation therapy | Prior Chemotherapy | Indolent lymphoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0442867
UMLS CUI [1,2]
C0205394
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [4]
C0279134
UMLS CUI [5]
C1514457
UMLS CUI [6]
C1334170
cns infiltration at diagnosis.
Beschreibung

Central Nervous System Infiltration

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3714787
UMLS CUI [1,2]
C0332448
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Diffuse Large B-Cell Lymphoma (DLBCL) NCT01066429

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
signing the informed consent.
boolean
C0021430 (UMLS CUI [1])
Diffuse Large B-Cell Lymphoma de novo | Primary Mediastinal Large B-Cell Lymphoma Mass Diameter | Follicular Lymphoma Ann Arbor lymphoma staging system
Item
histology: diffuse large b-cell lymphoma de novo (primary mediastinal b-cell lymphomas will be included provided that they have a mass greater than 7 cm in larger diameter) and follicular nhl grade 3b.
boolean
C0079744 (UMLS CUI [1,1])
C1515568 (UMLS CUI [1,2])
C1292754 (UMLS CUI [2,1])
C1306372 (UMLS CUI [2,2])
C1301886 (UMLS CUI [2,3])
C0024301 (UMLS CUI [3,1])
C0432516 (UMLS CUI [3,2])
International Prognostic Index Adjusted Age
Item
aaipi: 2-3.
boolean
C1512894 (UMLS CUI [1,1])
C3831006 (UMLS CUI [1,2])
Age
Item
age: between 18 and 70 years.
boolean
C0001779 (UMLS CUI [1])
General finding of patient ECOG performance status | General finding of patient WHO performance status scale | Organ function | FEV1 | Creatinine measurement, serum | Serum total bilirubin measurement | Communicable Disease control | White Blood Cell Count procedure | Platelet Count measurement | Exception Lymphomatous infiltration Bone Marrow | Exception Lymphomatous infiltration Spleen
Item
general condition (ecog/who): proper organic function, defined by: fevi ≥ 40%, serum creatinine < 150 µmol/l, serum bilirubin < 30 µmol/l, control of other medical conditions such as: infection, leukocytes ≥ 3.5 x 109/l and platelets ≥ 100 x 109/l (except if they are caused by lymphomatous infiltration of bone marrow or of the spleen).
boolean
C0424449 (UMLS CUI [1,1])
C1520224 (UMLS CUI [1,2])
C0424449 (UMLS CUI [2,1])
C1298650 (UMLS CUI [2,2])
C0678852 (UMLS CUI [3])
C0849974 (UMLS CUI [4])
C0201976 (UMLS CUI [5])
C1278039 (UMLS CUI [6])
C0009450 (UMLS CUI [7,1])
C0243148 (UMLS CUI [7,2])
C0023508 (UMLS CUI [8])
C0032181 (UMLS CUI [9])
C1705847 (UMLS CUI [10,1])
C2960101 (UMLS CUI [10,2])
C0005953 (UMLS CUI [10,3])
C1705847 (UMLS CUI [11,1])
C2960101 (UMLS CUI [11,2])
C0037993 (UMLS CUI [11,3])
Item Group
C0680251 (UMLS CUI)
HIV Seropositivity
Item
hiv-positive.
boolean
C0019699 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnancy or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Disease Serious compromises Therapeutic procedure
Item
serious disease compromising the performance of the therapeutic regimen.
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C2945640 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,4])
Malignant disease Other | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix | Prior radiation therapy | Prior Chemotherapy | Indolent lymphoma
Item
recent history of another malignant disease (except skin cancer different from melanoma or carcinoma in-situ of the cervix), prior radiotherapy or chemotherapy, history of indolent lymphoma.
boolean
C0442867 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C0279134 (UMLS CUI [4])
C1514457 (UMLS CUI [5])
C1334170 (UMLS CUI [6])
Central Nervous System Infiltration
Item
cns infiltration at diagnosis.
boolean
C3714787 (UMLS CUI [1,1])
C0332448 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video